Friday, July 10, 2026

pharma · Chronic Hepatitis D Infection · Chronic Hepatitis Delta Infection

Blue Earth Diagnostics

Blue Earth Diagnostics patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, GB HQ
2014 Founded
120 Employees
EMA registrant Type
Company details
Status
Public
HQ
Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, GB
Founded
2014
Employees
120
Programs
11
Drugs
12
Patents
0
Intelligence · Patents

Blue Earth Diagnostics patents

0 pharmaceutical patents indexed for Blue Earth Diagnostics. 0 expire within 24 months.

Blue Earth Diagnostics has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

No patents matched

Try a different expiry filter or check back as we index more USPTO records.

Frequently asked questions

How many patents does Blue Earth Diagnostics have?

0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Blue Earth Diagnostics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.